Clinical Trials Directory

Trials / Sponsors / VaxInnate Corporation

VaxInnate Corporation

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
UnknownStudy of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years
Influenza
Phase 22015-05-01
UnknownStudy of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years
Influenza
Phase 1 / Phase 22014-11-01
UnknownPhase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Influenza
Phase 12014-03-01
CompletedStudy of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Influenza
Phase 12012-09-01
CompletedSafety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
Influenza
Phase 12012-06-01
CompletedComparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy
Influenza
Phase 12010-07-01
CompletedSafety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age
Influenza
Phase 22009-09-01
CompletedStudy to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults
Influenza
Phase 12009-06-01
CompletedComparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing Wit
Influenza
Phase 1 / Phase 22009-06-01
CompletedSafety of VAX102 Vaccine Given With Seasonal Flu Vaccine in Healthy Adults
Influenza
Phase 12009-06-01
CompletedPhase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vacc
Influenza
Phase 12008-07-01
CompletedPhase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults
Influenza Infection
Phase 12007-09-01